Skip to main content
. 2015 Mar 24;5(1):19–25. doi: 10.5500/wjt.v5.i1.19

Figure 3.

Figure 3

Improvement of serum creatinine (mg/dL) after conversion to mammalian target of rapamycin inhibitors in different groups. Baseline: Serum creatinine just before conversion; DM: Diabetes mellitus; HT: Hypertension; Prot: Proteinuria.